- JNJ
- JOHNSON & JOHNSON
-
144.47+0.89 (+0.62%) 12/20 close, EST
- Signals
- Analysis
- Financials
- Charts
- Dividends
AI Signals
Trade Signals
- 3 months
- 6 months
- 1 year
Date | Signals | Price | Return |
---|---|---|---|
SELL | |||
BUY | |||
SELL | |||
Premium Service. Sign Up Now |
|||
24. 07/18 | BUY | 156.58 | - |
Johnson & Johnson is the world's largest healthcare company that offers a wide range of products, including baby products, beauty products, pharmaceuticals, and medical devices. It operates in three divisions: pharmaceuticals, medical devices, and consumer.
The pharmaceuticals and medical devices group accounts for approximately 80% of the revenue, driving the company's cash flow. In the pharmaceutical segment, the company focuses on therapeutic areas such as immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. In the medical devices field, it emphasizes orthopedic surgery, surgical instruments, vision care, and a few other areas.
In the consumer segment, the company provides products with a focus on baby care, beauty, oral healthcare, over-the-counter medicines, and women's health.
The total sales are distributed primarily in the United States (51.3%), followed by North America (7.2%), Europe (22.5%), and Asia/Pacific and Africa (19%).
Johnson & Johnson targets the general public and sells its products through retail stores and distribution companies. It directly distributes products for prescription use to wholesale suppliers, hospitals, and healthcare professionals. Additionally, it has research and collaboration relationships with Morphic Therapeutic.
Established in 1887, Johnson & Johnson is headquartered in New Brunswick, New Jersey.